Globe Life (GL) Aandelenoverzicht
Globe Life Inc. biedt via haar dochterondernemingen verschillende levensverzekeringen en aanvullende ziektekostenverzekeringen aan gezinnen met lagere midden- en middeninkomens in de Verenigde Staten. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 5/6 |
| Toekomstige groei | 1/6 |
| Prestaties in het verleden | 4/6 |
| Financiële gezondheid | 2/6 |
| Dividenden | 4/6 |
Beloningen
Risicoanalyse
GL Community Fair Values
Create NarrativeSee what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Globe Life Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$156.28 |
| 52 Week Hoogtepunt | US$157.92 |
| 52 Week Laag | US$116.73 |
| Bèta | 0.50 |
| 1 maand verandering | 2.44% |
| 3 maanden verandering | 8.41% |
| 1 Jaar Verandering | 27.83% |
| 3 jaar verandering | 48.64% |
| 5 jaar verandering | 47.46% |
| Verandering sinds IPO | 5,045.81% |
Recent nieuws en updates
Narratiefupdate • May 15
GL: Buybacks And Earnings Guidance Will Shape A Balanced Forward Outlook
Analysts have adjusted their price target for Globe Life to $147. This $1 change reflects updated views on slightly higher discount rates, more moderate revenue growth, a marginally stronger profit margin, and a modestly lower future P/E assumption.
Narratiefupdate • Apr 30
GL: Earnings Guidance And Buybacks Will Support Bullish Long Term Outlook
Analysts have kept their Globe Life price target steady at $199.00. This reflects only small adjustments to assumptions around revenue growth, profit margins, and future P/E that together leave their overall valuation view broadly unchanged.Recent updates
Narratiefupdate • May 15
GL: Buybacks And Earnings Guidance Will Shape A Balanced Forward Outlook
Analysts have adjusted their price target for Globe Life to $147. This $1 change reflects updated views on slightly higher discount rates, more moderate revenue growth, a marginally stronger profit margin, and a modestly lower future P/E assumption.Narratiefupdate • Apr 30
GL: Earnings Guidance And Buybacks Will Support Bullish Long Term Outlook
Analysts have kept their Globe Life price target steady at $199.00. This reflects only small adjustments to assumptions around revenue growth, profit margins, and future P/E that together leave their overall valuation view broadly unchanged.Narratiefupdate • Apr 15
GL: Updated Capital Returns And Slightly Lower P/E Assumptions Will Guide Balanced Outlook
Analysts now see Globe Life's fair value at $146.00, down from $150.00. This reflects slightly adjusted assumptions for revenue growth, profit margin and future P/E in their updated models.Narratiefupdate • Apr 01
GL: Higher P/E Assumptions And Capital Returns Will Shape Balanced Future Outcomes
Analysts have raised their price target on Globe Life to $150, up from $145. This change reflects updated assumptions for revenue growth, profit margins and future P/E multiples in their models.
Narratiefupdate • Mar 18
GL: Share Repurchases And Earnings Guidance Will Support Long-Term Upside
Analysts have adjusted their price target on Globe Life slightly higher to about $172 per share, reflecting updated assumptions for revenue growth, profit margin, discount rate, and future P/E. What's in the News Globe Life's board approved a quarterly dividend of $0.3300 per share, payable on May 1, 2026, to shareholders of record as of April 3, 2026 (Key Developments).Seeking Alpha • Mar 14
Globe Life: Undervalued Insurance For Your Portfolio
Summary Globe Life offers a compelling long-term dividend growth profile, despite its modest 0.8% yield, making it ideal for future-focused portfolios. GL’s affordable, sticky policies drive recurring revenue and organic growth, supported by a large underinsured market and expanding exclusive agent force. Trading at a 17% discount to a $171 fair value estimate, GL’s forward P/E of 9.2 is well below historical averages, positioning it for potential revaluation. With a low payout ratio and a 20-year dividend growth streak, GL targets double-digit annual dividend hikes and could deliver 11% annual total returns through 2031. Read the full article on Seeking AlphaNarratiefupdate • Mar 04
GL: Future Earnings Outlook And Buybacks Will Support Bullish View
Analysts have maintained their Globe Life price target at $199, citing updated model inputs that reflect slightly different assumptions for the discount rate, revenue growth, profit margin, and future P/E, while still arriving at the same fair value estimate. What's in the News Globe Life's board approved a quarterly dividend of $0.33 per share, payable on May 1, 2026, to shareholders of record as of April 3, 2026 (company announcement).Narratiefupdate • Feb 18
GL: Buybacks And Earnings Outlook Will Support Long-Term Upside
Analysts have adjusted their price target on Globe Life to $171.40 from $168.30. This reflects updated assumptions around revenue growth, profit margins, the discount rate, and future P/E expectations.Narratiefupdate • Feb 04
GL: Higher Revenue Outlook And P/E Assumptions Will Shape Balanced Future Returns
Analysts have lifted their price target on Globe Life from US$111.00 to US$145.00, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E, which together support a higher valuation framework. Valuation Changes Fair Value: price target updated from US$111.00 to US$145.00, representing a sizeable upward reset in the valuation estimate.Narratiefupdate • Jan 20
GL: Future Earnings Guidance And Buybacks Will Support Bullish View
Analysts have raised their price target on Globe Life from about $185 to $199, citing updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Globe Life issued earnings guidance for 2025, projecting net operating income between $14.40 and $14.60 per diluted common share for the year ending December 31, 2025 (company guidance).Narratiefupdate • Jan 06
GL: Steady Outlook And Ongoing Buybacks Will Support Long-Term Upside
Analysts have kept their price target for Globe Life broadly steady around $168.30, reflecting minor adjustments to assumptions for revenue growth, profit margin and future P/E that did not materially change their overall valuation view. What's in the News Globe Life issued earnings guidance for 2025, projecting net operating income between $14.40 and $14.60 per diluted share for the year ending December 31, 2025 (Key Developments).Narratiefupdate • Dec 21
GL: Future Earnings Visibility And Buybacks Will Drive Long-Term Upside Potential
Analysts have raised their price target on Globe Life by approximately 1 dollar to reflect slightly higher modeled fair value, modestly improved margin and growth assumptions, and a marginally higher future P E multiple. What's in the News Issued earnings guidance for 2025, projecting net operating income of $14.40 to $14.60 per diluted share, signaling steady profit expectations (company guidance) Provided 2026 outlook with net operating income per share estimated between $14.60 and $15.30, suggesting continued earnings growth beyond next year (company guidance) Repurchased 1,274,691 shares between July 1 and September 30, 2025, equal to 1.57% of shares outstanding, for $172.95 million (buyback update) Reached 98.88% completion of a long running share repurchase program, totaling 143,773,686 shares bought back for $9,831.8 million since its announcement in August 2005 (buyback update) Valuation Changes Fair Value: increased slightly from $166.70 to $168.30 per share, reflecting a modestly higher modeled intrinsic value.Narratiefupdate • Dec 07
GL: Expanding Earnings Guidance Will Drive Long-Term Upside Potential
Analysts have modestly raised their price target on Globe Life to approximately $166.70 per share from about $166.27. They cite slightly stronger projected profit margins, a marginally lower discount rate, and a small uptick in expected revenue growth and future earnings multiples.Narratiefupdate • Nov 23
GL: Share Buyback Momentum And Earnings Guidance Will Drive Upside
Narrative Update on Globe Life: Analyst Price Target Adjustment Analysts have slightly lowered their fair value estimate for Globe Life by $0.18 to $166.27, citing marginal changes in projected revenue growth and profit margin expectations. What's in the News Globe Life Inc.Narratiefupdate • Nov 08
GL: Share Repurchases And Earnings Guidance Will Drive Future Upside
Analysts have raised their price target for Globe Life slightly, increasing it from $166.27 to $166.45, based on adjusted expectations for revenue growth and profitability. What's in the News Globe Life Inc.Narratiefupdate • Oct 25
Share Repurchases And Earnings Outlook Will Support Insurance Sector Expansion
Narrative Update: Globe Life Analyst Price Target Revision Analysts have slightly raised their fair value estimate for Globe Life, increasing the target from $165.73 to $166.27 per share. This change reflects improved expectations for profit margin and a stable growth outlook.Narratiefupdate • Oct 11
Digital Underwriting And Agent Expansion Will Shape Insurance Future
Narrative Update: Globe Life Analyst Price Target Adjustment Analysts have raised their fair value estimate for Globe Life from $161.55 to $165.73, citing modest improvements in projected revenue growth and a slightly lower discount rate as key factors supporting the upward adjustment. What's in the News Globe Life Inc.Narratiefupdate • Sep 27
Digital Underwriting And Agent Expansion Will Shape Insurance Future
Globe Life’s valuation metrics, including Future P/E and Discount Rate, remained essentially stable, resulting in only a marginal increase in the consensus Analyst Price Target from $160.18 to $161.55. What's in the News SEC concludes its investigation of Globe Life and does not intend to recommend an enforcement action.Seeking Alpha • Jan 23
Globe Life: A Stalwart That Can Balance Growth And Profitability
Summary Globe Life demonstrates steady EPS growth due to disciplined underwriting and cost efficiency. The company targets lower to middle-income families, maintaining stable annualized premiums and high underwriting margins. Globe Life's strong liquidity, high RBC ratio, and quality investment portfolio bolster its financial health. Shares are a buy with long-term price target of $180. Read the full article on Seeking AlphaSeeking Alpha • Sep 13
Globe Life: Boring, Which Is Good As A Policyholder-But Not As An Investor
Summary Globe Life's stable share price and low dividend yield make it a lackluster investment with limited growth potential and better alternatives available. The company’s business model and performance are respectable, but there are no significant catalysts for future gains. Despite a recent share buyback, Globe Life trails its peers and broader market indices in total return, making it a "pass" for investors. Read the full article on Seeking Alpha
Nieuw narratief • Aug 25
Enhanced Credibility And Strategic Growth Initiatives Promise Bright Prospects
Audit Committee's findings boost Globe Life's credibility and investor confidence by clarifying financial integrity, influencing stock value positively.Seeking Alpha • Jun 24
Globe Life: A Small Bet That The Recent Controversy Will Blow Over
Summary Globe Life Inc. shares rebounded sharply after a short report by Fuzzy Panda, caused a short-lived over 50% drop in the stock. Despite the controversy, Globe Life reported strong 1Q24 financials, increased its FY24 outlook, and has seen some recent insider purchases in the shares. Allegations of fraud and misconduct did prompt the SEC to open an informal inquiry. Despite the rebound, the stock is still cheap on a P/E basis. An analysis around Globe Life follows in the paragraphs below. Read the full article on Seeking AlphaSeeking Alpha • Apr 15
Globe Life: Betting On A Bounce To $80
Summary Globe Life experienced a significant drop in stock price after a report from Fuzzy Panda Research accused the company of unethical practices. The report compared Globe Life to other life insurance companies to build its negative narrative but did not assess industry standards or behaviors. In particular, Primerica. Fuzzy Panda held a $64.35 price target. GL has dropped below that mark. GL now has valuation metrics well below the industry average and significantly below PRI, it's most direct comparable as a life insurance company with an MLM sales structure. I believe that the stock price will bounce back to $80 or higher due to short sellers covering their positions and bullish investor speculation. Read the full article on Seeking AlphaRendement voor aandeelhouders
| GL | US Insurance | US Markt | |
|---|---|---|---|
| 7D | 4.3% | -0.6% | 1.2% |
| 1Y | 27.8% | -6.7% | 28.7% |
Rendement versus industrie: GL overtrof de US Insurance industrie, die het afgelopen jaar een rendement -6.7 % opleverde.
Rendement versus markt: GL kwam overeen met de US markt, die het afgelopen jaar een rendement opleverde van 28.7 %.
Prijsvolatiliteit
| GL volatility | |
|---|---|
| GL Average Weekly Movement | 2.8% |
| Insurance Industry Average Movement | 4.4% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: GL heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van GL is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1900 | 3,695 | Frank Svoboda | home.globelifeinsurance.com |
Globe Life Inc. biedt via haar dochterondernemingen verschillende levensverzekeringen en aanvullende ziektekostenverzekeringen aan gezinnen met lagere midden- en middeninkomens in de Verenigde Staten. Het bedrijf is actief in drie segmenten: Levensverzekeringen, aanvullende ziektekostenverzekeringen en beleggingen. Het bedrijf biedt levensverzekeringen, levensverzekeringen op termijn en andere levensverzekeringsproducten, evenals levensverzekeringen voor kinderen; Medicare-aanvullingen en aanvullende ziektekostenverzekeringsproducten met een beperkt voordeel, zoals ongevallen-, kanker-, kritieke ziekte-, hart- en intensieve zorgverzekeringen en andere gezondheidsproducten; en producten voor slotkosten, overlijden door ongeval, hypotheekbescherming en ziekenhuisverzekeringen.
Globe Life Inc. Samenvatting
| GL fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$12.13b |
| Inkomsten(TTM) | US$1.18b |
| Inkomsten(TTM) | US$6.07b |
10.3x
Koers/Winstverhouding2.0x
P/S-verhoudingIs GL overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| GL resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$6.07b |
| Kosten van inkomsten | US$4.02b |
| Brutowinst | US$2.05b |
| Overige uitgaven | US$871.51m |
| Inkomsten | US$1.18b |
Laatst gerapporteerde inkomsten
Mar 31, 2026
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 15.16 |
| Brutomarge | 33.73% |
| Nettowinstmarge | 19.38% |
| Schuld/Eigen Vermogen Verhouding | 53.6% |
Hoe presteerde GL op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
0.8%
Huidig dividendrendement8%
UitbetalingsratioBetaalt GL een betrouwbaar dividend?
Zie GL dividendgeschiedenis en benchmarks| Globe Life dividenddata | |
|---|---|
| Ex Dividend Datum | Jul 06 2026 |
| Betaaldatum dividend | Jul 31 2026 |
| Dagen tot Ex-dividend | 41 days |
| Dagen tot dividendbetaaldatum | 66 days |
Betaalt GL een betrouwbaar dividend?
Zie GL dividendgeschiedenis en benchmarksBedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/26 10:03 |
| Aandelenkoers aan het einde van de dag | 2026/05/22 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Globe Life Inc. wordt gevolgd door 30 analisten. 8 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Jay Gelb | Barclays |
| Jack Matten | BMO Capital Markets Equity Research |
| null null | BMO Capital Markets Equity Research |